Insider Transactions Reported by 22 Insiders of RESMED INC

Symbol
RMD on NYSE, RSMDF on OTC
Location
San Diego, CA

Insiders trading volume in the past year

RESMED INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Chairman Michael J. Farrell Chairman and CEO, Director $125,918,899 -$21,542,961 -15% 09 Mar 2026
Robert Andrew Douglas Special Advisor $40,348,939 02 Jan 2024
Brett Sandercock Chief Financial Officer $21,487,078 -$6,569,488 -23% 02 Mar 2026
Chairman Emeritus Peter C. Farrell Director $16,668,232 -$4,187,818 -20% 04 Mar 2026
David Pendarvis Chief Administrative Officer $13,694,449 30 Jun 2023
James Hollingshead Former President, SRC Business $11,709,167 30 Jun 2022
Justin Leong Chief Product Officer $7,699,967 20 Nov 2025
Ronald R. Taylor Director $6,570,755 20 Nov 2025
Carol Burt Director $4,991,131 20 Nov 2025
Kaushik Ghoshal Chief Commercial Officer, SaaS $4,985,543 05 Aug 2025
Richard Sulpizio Director $4,720,566 19 Nov 2025
Rajwant Sodhi President, SaaS Business $4,079,688 07 Oct 2021
Harjit Gill Director $2,901,944 20 Nov 2025
Karen Drexler Director $2,812,286 20 Nov 2025
Global Michael J. Rider Global General Counsel $2,519,660 -$120,046 -4.5% 04 Feb 2026
RESMED INC Director $2,109,668 18 Nov 2021
Desney Tan Director $1,592,090 20 Nov 2025
Lucile Blaise President, Sleep & RC Business $1,572,750 16 Nov 2023
John Hernandez Director $1,357,600 -$739,289 -35% 20 Nov 2025
Jan de Witte Director $1,086,555 -$1,132,837 -51% 25 Nov 2025
Christopher DelOrefice Director $642,724 20 Nov 2025
Nicole Mowad-Nassar Director $539,549 24 Nov 2025

Recent Insider Transactions by Companies or Individuals for RESMED INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Chairman Michael J. Farrell RMD ResMed Common Stock Sale -1.06% $1,252,902 $251.03 -4,991 466,223 09 Mar 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Exercise 1.07% 4,991 471,214 09 Mar 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Options Exercise -11.1% -4,991 39,930 09 Mar 2026 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Sale -3.09% $520,440 $260.22 -2,000 62,773 04 Mar 2026 Direct
Brett Sandercock RMD ResMed Common Stock Sale -1.17% $254,300 $254.30 -1,000 84,495 02 Mar 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Sale -1.06% $1,366,436 $273.78 -4,991 466,223 09 Feb 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Exercise 1.07% 4,991 471,214 09 Feb 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Options Exercise -10% -4,991 44,921 09 Feb 2026 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Sale -3% $502,620 $251.31 -2,000 64,773 04 Feb 2026 Direct
Global Michael J. Rider RMD ResMed Common Stock Sale -0.51% $13,000 $260.00 -50 9,691 04 Feb 2026 Direct
Brett Sandercock RMD ResMed Common Stock Sale -1.16% $257,030 $257.03 -1,000 85,495 02 Feb 2026 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Sale -2.91% $497,660 $248.83 -2,000 66,773 07 Jan 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Sale -1.06% $1,240,065 $248.46 -4,991 466,223 07 Jan 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Exercise 1.07% 4,991 471,214 07 Jan 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Options Exercise -9.09% -4,991 49,912 07 Jan 2026 Direct
Brett Sandercock RMD ResMed Common Stock Sale -1.14% $241,750 $241.75 -1,000 86,495 02 Jan 2026 Direct
Global Michael J. Rider RMD ResMed Common Stock Sale -0.51% $12,088 $241.75 -50 9,741 02 Jan 2026 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Sale -1.06% $1,254,796 $251.41 -4,991 466,223 08 Dec 2025 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Exercise 1.07% 4,991 471,214 08 Dec 2025 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Options Options Exercise -8.33% -4,991 54,903 08 Dec 2025 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Sale -2.83% $502,940 $251.47 -2,000 68,773 03 Dec 2025 Direct
Global Michael J. Rider RMD ResMed Common Stock Sale -0.51% $12,208 $244.16 -50 9,791 01 Dec 2025 Direct
Brett Sandercock RMD ResMed Common Stock Sale -1.13% $244,160 $244.16 -1,000 87,495 01 Dec 2025 Direct
Jan de Witte RMD ReMed Common Stock Sale -32.5% $524,025 $255.00 -2,055 4,261 25 Nov 2025 Direct
Michael J. Farrell RMD ResMed Common Stock Options Award 33,288 33,288 24 Nov 2025 Direct
Peter C. Farrell RMD ResMed Common Stock Options Award 1,331 1,331 24 Nov 2025 Direct
Nicole Mowad-Nassar RMD ResMed Common Stock Options Award 1,331 1,331 24 Nov 2025 Direct
Justin Leong RMD ReMed Common Stock Award 6.8% 1,848 29,028 20 Nov 2025 Direct
John Hernandez RMD ResMed Common Stock Award 26.5% 1,073 5,118 20 Nov 2025 Direct
Nicole Mowad-Nassar RMD ResMed Common Stock Award 222.4% 536 777 20 Nov 2025 Direct
Desney Tan RMD ResMed Common Stock Award 21.8% 1,073 6,002 20 Nov 2025 Direct
Harjit Gill RMD ResMed Common Stock Award 10.9% 1,073 10,940 20 Nov 2025 Direct
Karen Drexler RMD ResMed Common Stock Award 11.3% 1,073 10,602 20 Nov 2025 Direct
Carol Burt RMD ResMed Common Stock Award 99.1% 1,073 2,156 20 Nov 2025 Direct
Ronald R. Taylor RMD ResMed Common Stock Award 4.53% 1,073 24,771 20 Nov 2025 Direct
Brett Sandercock RMD ResMed Common Stock Award 3.16% 2,710 88,495 20 Nov 2025 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Tax liability -1.54% -7,297 466,223 20 Nov 2025 Direct
Chairman Michael J. Farrell RMD ResMed Common Stock Award 2.95% 13,551 473,520 20 Nov 2025 Direct
Christopher DelOrefice RMD ResMed Common Stock Award 79.5% 1,073 2,423 20 Nov 2025 Direct
Jan de Witte RMD ReMed Common Stock Award 20.5% 1,073 6,316 20 Nov 2025 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Award 0.76% 536 70,773 20 Nov 2025 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Tax liability -9.43% -7,314 70,238 14 Nov 2025 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Options Exercise 17.3% 11,442 77,552 14 Nov 2025 Direct
Chairman Emeritus Peter C. Farrell RMD ResMed Common Stock Options Options Exercise -100% -11,442 0 14 Nov 2025 Direct
Peter C. Farrell RMD ResMed Common Stock Sale -2.94% $504,100 $252.05 -2,000 66,110 12 Nov 2025 Direct
Harjit Gill RMD ResMed Common Stock Tax liability -0.39% -38.21 9,867 11 Nov 2025 Direct
Global Michael J. Rider RMD ResMed Common Stock Tax liability -13.4% -1,525 9,841 11 Nov 2025 Direct
Jan de Witte RMD ReMed Common Stock Tax liability -1.44% -76.45 5,242 11 Nov 2025 Direct
Jan de Witte RMD ReMed Common Stock Sale -8.39% $121,872 $250.25 -487 5,319 11 Nov 2025 Direct
Michael J. Farrell RMD ResMed Common Stock Tax liability -1.69% -7,897 459,969 11 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.